Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?


Eskazan A. E.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, cilt.84, sa.8, ss.1635-1638, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 84 Konu: 8
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/bcp.13637
  • Dergi Adı: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
  • Sayfa Sayıları: ss.1635-1638